神经外科手术室人工智慧市场：按组件、应用、最终用户、技术、部署模式、手术类型和解剖目标划分——2025-2032年全球预测

预计到 2032 年，神经外科手术室人工智慧市场规模将达到 14.0982 亿美元，复合年增长率为 33.39%。

关键市场统计数据
基准年 2024	1.4062亿美元
预计年份：2025年	1.8724亿美元
预测年份 2032	1,409,820,000 美元
复合年增长率 (%)	33.39%

权威洞见人工智慧如何即时变革神经外科工作流程、术中决策与手术室效率

手术室正朝着智慧化方向发展，人工智慧 (AI) 可即时辅助手术决策、影像撷取和器械控制。在神经外科领域，这些进步与需要极高精度、动态术中成像以及对生理和影像数据进行持续解读的手术密切相关。本执行摘要阐述了临床需求与人工智慧解决方案的交会点，重点介绍了各项技术如何融合重塑围手术全期工作流程和临床医师的工作环境。

在外科手术的各个阶段，人工智慧正从辅助分析发展成为支援影像引导切除、机器人辅助和预测性工作流程调整的嵌入式功能。下文将摘要技术、临床检验重点、供应商模式以及相关人员需要考虑的监管方面的核心转变。本文旨在指导高阶管理层、临床负责人和商业化团队做出策略选择，这些选择将决定未来几年人工智慧的普及速度和临床影响。

影像、导航、机器人技术和服务模式的进步如何融合，进而为神经外科手术室和采购系统带来系统性改变？

由于感测技术、机器感知和机器人精准度的不断成熟，神经外科手术室格局正在经历一场变革。成像系统如今能够提供高度精确的资料流，供人工智慧模型在术中进行分析，从而实现即时组织表征、切缘检测和导航校正。同时，导航平台与机器人系统和分析层的整合度日益提高，引领该领域朝着协作式、半自动任务执行的方向发展，从而减轻手术团队的认知负荷。

随着硬体和软体的不断引入，服务范围的扩展进一步强化了这些变化。整合服务正在发展，涵盖资料编配和传统影像设备之间的互通性，而培训和维护服务对于维持临床可靠性和运作至关重要。因此，经营模式正从单纯的资本设备销售转向包含设备、预测软体和持续临床支援的捆绑式解决方案。这种系统性的演变正在改变整个医疗系统的采购标准、临床医生培训课程和资本规划重点。

分析关税调整和贸易政策趋势，这些调整和趋势将重塑神经外科人工智慧系统的供应链、筹资策略和购买行为。

政策变化和关税调整会对高度复杂医疗技术的供应链、零件采购和筹资策略产生连锁反应。近期关税措施和贸易不确定性导致製造商和医疗系统面临零件成本上涨、前置作业时间延长且更难以预测，以及重新评估供应商集中度风险的必要性。包含精密机械部件、先进成像检测器和专用伺服马达的硬体元件尤其容易受到进口关税和贸易壁垒变化的影响。

随着时间的推移，这些压力可能会加速供应商多元化和在地化策略的实施，设备製造商会尽可能地将关键的组装和子组装流程迁回本国或邻近地区。软体和云端基础服务受到的影响则有所不同。虽然关税的实际影响相对较小，但跨境资料传输政策、託管成本和合约义务可能会增加总体拥有成本。为应对采购成本压力，医疗系统可能会优先考虑模组化架构、标准化介面以及将某些风险转移给供应商的服务协议。在临床方面，关税造成的干扰将减缓设备更新周期和新型、功能更强大的系统的应用，从而导致功能可用性与广泛临床应用之间存在时间差。随着相关人员重新调整应对措施，他们可能会更加重视强有力的供应商管治、多年采购协议和策略性库存管理。

整合细分观点将元件、应用、使用者、技术、部署模式和手术流程连结起来，以揭示采用驱动因素和价值创造领域。

从细分观点，我们可以清楚地看到不同产品层级、临床应用和客户类型中价值累积的领域和不同的投资重点。组件层面的差异表明，虽然硬体仍然是基础，成像、导航和机器人系统构成了与患者和临床团队的实际接触点，但服务和软体才是持续运作和临床价值提案。整合、维护和培训服务对于充分发挥硬体效用将变得日益重要，而人工智慧平台、分析软体和预测演算法将成为提升术中决策品质和工作流程效率的关键槓桿。

应用细分决定了对延迟、检验和监管证据的要求。术中影像方式（CT、MRI、超音波）各有不同的限制和整合需求，而预测分析用例（例如结果预测和工作流程优化）则需要纵向临床数据和互通性。机器人辅助涵盖神经科学用内视镜机器人和机器人辅助显微镜，每种机器人都有其独特的控制、触觉回馈和可靠性要求。最终使用者类型（例如门诊手术中心、医院/诊所和研究机构）会影响采购和实施偏好，并进而影响服务模式和支援等级。技术选择（例如采用 3D 重建和影像分割的电脑视觉、采用卷积和循环架构的深度学习、使用监督和非监督方法的机器学习、应用于临床报告分析和文献挖掘的自然语言处理）决定了检验路径和计算需求。云端环境和本地环境之间的部署选项会影响资料管治、延迟和升级频率。临床手术重点领域，例如深部脑部刺激、癫痫手术和肿瘤切除，以及脑部和脊髓等解剖目标，进一步提高了对精准度、对准性和术中回馈迴路的要求。从这些交织的细分市场角度审视市场，可以发现临床需求、技术可行性和采购标准相契合的领域，加速技术的应用。

美洲、欧洲、中东和非洲以及亚太地区不同的管理体制、采购模式和临床基础设施如何影响技术采纳轨迹和供应商策略

区域特征对技术采纳、监管参与和临床检验的进程有显着影响。在美洲，医疗系统往往强调以结果为导向的采购、强大的机构间监测网络以及对早期临床检验的投资意愿，从而加速试验计画和分阶段推广。此外，神经外科专科中心和学术中心的高度集中也有利于快速产生实证医学证据和进行临床医生培训，进而促进技术的更广泛应用。

在欧洲、中东和非洲，监管环境和报销框架决定着科技应用的时机和所需的证据包。部分地区的成本控制压力推动了扩充性、互通性解决方案的需求，这些解决方案需能显着提高吞吐量和临床疗效。同时，该地区部分地区专科医疗资源分配不均和医疗能力受限，为透过远距协助模式和云端分析拓展专业知识创造了机会。在亚太地区，医院的快速扩张、政府主导的技术推广计划以及具有竞争力的本地製造业基础，共同推动了筹资策略的多元化。该地区通常需要在积极采用机器人技术和诊断成像技术的同时，高度重视成本效益和供应链韧性。

企业透过整合解决方案、临床证据产生和创新商业模式追求产业领先地位，其竞争行为和策略要务也随之而来。

主要企业的行动都围绕着几个策略重点展开，这些重点将决定它们的市场定位和长期竞争力。首先，能够整合端到端解决方案（将影像和导航设备与检验的人工智慧软体和强大的服务相结合）的企业，将提高客户的转换成本，并为高额合约模式提供合理的依据。其次，临床系统整合商、影像设备供应商和专业人工智慧开发商之间的伙伴关係将加速监管申报和临床研究，并将成为常态，共用风险和证据产生责任。

第三，成功的公司会投资长期临床检验和真实世界证据项目，以证明其安全性、可重复性和对工作流程的影响。这些项目对于赢得临床医生的信任和付款方的认可至关重要。第四，将模组化和互通性融入其设计的公司可以减少与现有医院基础设施的整合摩擦，并缩短采购週期。最后，商业模式正在从传统的资本销售多元化发展，涵盖管理服务、按绩效付费合约和分析订阅许可等模式，这些模式将供应商的奖励与临床绩效和运转率挂钩。观察这些趋势有助于制定竞争策略和选择潜在合作伙伴。

为市场领导提供切实可行的策略倡议，以加速产品推广、降低实施风险，并使商业模式与临床结果和采购实务保持一致。

产业领导者应采取平衡的策略方针，兼顾临床检验、采购流程的复杂性和技术差异化。优先透过多中心研究和临床医生主导的试点计画来建立可验证的临床证据，这些研究和试点计画不仅要衡量技术准确性，还要衡量对工作流程的影响、使用者接受度和后续临床结果。同时，透过建置将硬体和软体与整合、培训和维护服务捆绑在一起的商业性提案，降低早期采用者的营运阻力，从而降低客户风险。

为降低供应链和政策风险，企业应考虑零件采购多元化，并选择性地在本地生产关键组件。投资于可互通架构和开放API对于促进与医院资讯系统和现有影像设备的整合至关重要。在技​​术方面，应着重开发可解释模型和人机互动介面，以增强外科医生的控制力并提高监管合规性。最后，与领先的临床中心和支付方建立伙伴关係至关重要，以便建立将技术应用与临床和营运指标改善联繫起来的共用价值提案。

我们采用稳健的多面向调查方法，结合临床医师访谈、技术评估、监管审查和供应链分析，以得出基于证据的结论。

本报告的调查方法结合了初步研究、严谨的二次研究和临床检验，以确保研究结果具有实证性和可操作性。初步研究包括对执业神经外科医师、手术室护理师、医疗设备技术人员、医院采购负责人和技术主管进行结构化访谈，并在条件允许的情况下辅以对术中工作流程的直接观察。这些初步研究结果与医疗设备技术规范、监管文件和同行评审的临床文献进行交叉比对，以检验结论并为结果提供背景资讯。

我们的技术评估涵盖演算法方法、训练资料集、计算资源需求和整合复杂性。我们的供应链映射追踪组件来源、组装地点和物流风险，从而揭示潜在漏洞。我们的监管审查涵盖设备分类、核准时间表和上市后监管义务。我们采用多层资料整合方法，综合考虑临床影响、技术成熟度和商业性可行性，以提出平衡的建议。我们避免在定性和证据分析之外进行量化的市场规模预测。

本文概述了临床检验、互通性设计和强大的商业策略如何为人工智慧在神经外科领域的可持续应用奠定基础。

人工智慧正从一项前景广阔的辅助技术转变为支撑更安全、更精准神经外科手术的基础层。当可靠的硬体、检验的演算法和服务模式融合，从而降低术中不确定性、提高手术效率并拓展专家技能时，这项技术的真正价值才能得以实现。然而，实现这一愿景需要严格的临床检验、可互操作系统设计、稳健的供应链以及能够协调供应商和医疗机构之间奖励的周全的商业模式。

投资于模组化架构、长期循证计画和强大的临床医生参与计画的相关人员，将能够最大限度地发挥人工智慧赋能神经外科的临床和经济效益。政策制定者和医院经营团队应推广衡量病患疗效和营运绩效实际改善的框架，而供应商则应强调可解释性、可靠性和可维护性作为核心产品特性。这些要素共同构成了在神经外科手术室中可持续且负责任地应用人工智慧的基础。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 利用深度学习模型引入一种用于脑切除手术中神经组织边界的自动化即时检测系统
• 引入人工智慧驱动的预测分析技术，以预测神经外科患者特定的手术风险和结果
• 推出一款基于机器学习的扩增实境系统，用于在复杂颅脑手术中为外科医生提供指导。
• 整合以人工智慧为基础的工作流程优化平台，以改善神经外科手术的排程并缩短手术时间
• 开发融合电生理讯号和影像资料的多模态人工智慧演算法，用于术中决策支援
• 利用联邦学习框架，使用神经外科影像资料进行多机构人工智慧训练，同时保护病患隐私
• 新兴的人工智慧视觉系统整合机器人技术可提高微创神经介入手术的精准度

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 神经外科手术室人工智慧市场（按组件划分）

• 硬体
  • 影像系统
  • 导航系统
  • 机器人系统
• 服务
  • 整合服务
  • 维护服务
  • 培训服务
• 软体
  • 人工智慧平台
  • 分析软体
  • 预测演算法

第九章 按应用领域分類的神经外科手术室人工智慧市场

• 术中影像
  • CT
  • MRI
  • 超音波
• 预测分析
  • 治疗结果预测
  • 工作流程优化
• 机器人辅助
  • 神经科学用内视镜机器人
  • 机器人辅助显微镜
• 手术导航
  • 电磁导航
  • 光学导航

第十章 神经外科手术室人工智慧市场（依最终用户划分）

• 门诊手术中心
• 医院和诊所
• 研究所

第十一章 神经外科手术室人工智慧市场（依技术划分）

• 电脑视觉
  • 三维重建
  • 影像分割
• 深度学习
  • 卷积类神经网路
  • 递迴神经网
• 机器学习
  • 监督式学习
  • 无监督学习
• 自然语言处理
  • 临床报告分析
  • 文献挖掘

第十二章 神经外科手术室人工智慧市场（依部署方式划分）

• 云
• 本地部署

第十三章 神经外科手术室人工智慧市场（依手术类型划分）

• 深部脑部刺激
• 癫痫手术
• 肿瘤切除

14. 依解剖目标分類的神经外科手术室人工智慧市场

• 脑
• 脊髓

第十五章 神经外科手术室人工智慧市场（按地区划分）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十六章 神经外科手术室人工智慧市场（依产业划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十七章 各国神经外科手术室人工智慧市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十八章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips NV
  • Medtronic plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Globus Medical, Inc.
  • Brainlab AG
  • Renishaw plc
  • Carl Zeiss Meditec AG

The Artificial Intelligence in Neurology Operating Room Market is projected to grow by USD 1,409.82 million at a CAGR of 33.39% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 140.62 million
Estimated Year [2025]	USD 187.24 million
Forecast Year [2032]	USD 1,409.82 million
CAGR (%)	33.39%

An authoritative orientation to how artificial intelligence is reshaping neurosurgical workflows, intraoperative decision-making, and operating room efficiency in real time

The operating room is evolving into an intelligent environment where artificial intelligence augments surgical decision-making, imaging interpretation, and device control in real time. In neurology, these advances intersect with procedures that demand extreme precision, dynamic intraoperative imaging, and continuous interpretation of physiological and imaging data. This executive summary frames the intersection of clinical imperatives and AI-enabled solutions, focusing on how technologies are converging to redefine perioperative workflows and clinician ergonomics.

Across procedural stages, AI is moving from adjunctive analytics toward embedded functionality that supports image-guided resection, robotic assistance, and predictive workflow orchestration. The content that follows distills core shifts in technology, clinical validation priorities, supplier models, and regulatory considerations that stakeholders must weigh. It is intended to orient senior executives, clinical leaders, and commercialization teams to the strategic choices that will determine adoption velocity and clinical impact over the coming years.

How converging advances in imaging, navigation, robotics, and service models are driving systemic transformation in neurosurgical operating rooms and procurement

The landscape of neurology operating theaters is experiencing transformative shifts driven by the maturation of sensing modalities, machine perception, and robotic precision. Imaging systems now feed high-fidelity data streams that AI models can analyze intraoperatively, enabling real-time tissue characterization, margin detection, and navigation corrections. Concurrently, navigation platforms are becoming more tightly integrated with robotic systems and analytics layers, moving the field toward coordinated, semi-autonomous task execution that reduces cognitive load on surgical teams.

These shifts are reinforced by expanding lines of service that accompany hardware and software deployments. Integration services are evolving to cover data orchestration and interoperability across legacy imaging modalities, while training and maintenance services are critical to sustain clinical confidence and uptime. As a result, business models are transitioning from pure capital equipment sales to bundled solutions that combine devices, predictive software, and ongoing clinical support. This systemic evolution is altering procurement criteria, clinician training curricula, and capital planning priorities across health systems.

Analysis of how tariff adjustments and trade policy dynamics are reshaping supply chains, sourcing strategies, and procurement behavior for neurosurgical AI systems

Policy changes and tariff adjustments can have cascading effects across supply chains, component sourcing, and procurement strategies for high-complexity medical technologies. In the context of recent tariff actions and trade uncertainties, manufacturers and health systems face upward pressure on component costs, longer and less predictable lead times, and the need to reassess supplier concentration risks. Hardware elements that incorporate precision mechanical components, advanced imaging detectors, or specialized servomotors are particularly exposed to shifts in import duties and trade barriers.

Over time, these pressures tend to accelerate supplier diversification and localization strategies, prompting device makers to onshore or nearshore key assembly and subassembly operations where feasible. Software and cloud-based services experience a different set of impacts: while they are less vulnerable to physical tariffs, they are affected by cross-border data transfer policies, hosting costs, and contractual obligations that can increase total cost of ownership. Health systems responding to procurement cost pressures may prioritize modular architectures, standardized interfaces, and service agreements that transfer certain risks to vendors. Clinically, tariff-driven disruptions can slow replacement cycles and delay the diffusion of newer, more capable systems, creating a temporal gap between capability availability and broad clinical adoption. As stakeholders recalibrate, the emphasis on robust supplier governance, multi-year procurement contracts, and strategic inventory management will grow.

An integrated segmentation perspective that links components, applications, users, technologies, deployments, and surgical procedures to reveal adoption drivers and value pools

A segmentation-aware view clarifies where value accrues and how investment priorities differ across product layers, clinical uses, and customer types. Component-level distinctions reveal that hardware remains foundational, with imaging systems, navigation systems, and robotic systems forming the tangible interface to the patient and clinical team, while services and software create the sustained operational and clinical value proposition. Integration, maintenance, and training services are increasingly pivotal for unlocking hardware utility, and AI platforms, analytics software, and predictive algorithms are the primary levers for improving intraoperative decision quality and workflow efficiency.

Application segmentation shapes requirements for latency, validation, and regulatory evidence. Intraoperative imaging modalities-CT, MRI, and ultrasound-have differing constraints and integration needs, while predictive analytics use cases such as outcome prediction and workflow optimization demand longitudinal clinical data and interoperability. Robotic assistance spans neuroendoscopic robots and robot-assisted microscopy, each with distinct control, haptics, and reliability expectations. End-user typologies, including ambulatory surgical centers, hospitals and clinics, and research institutes, create diverse procurement and deployment preferences that influence service models and support levels. Technology choices-computer vision with 3D reconstruction and image segmentation, deep learning instantiated through convolutional and recurrent architectures, machine learning with supervised and unsupervised approaches, and natural language processing applied to clinical report analysis and literature mining-determine validation pathways and compute requirements. Deployment options between cloud and on-premise environments influence data governance, latency, and upgrade cadence. Clinical procedure focus areas such as deep brain stimulation, epilepsy surgery, and tumor resection, and anatomical targets including brain and spinal cord, further refine requirements for precision, registration, and intraoperative feedback loops. Viewing the market through these intersecting segmentation lenses helps reveal where clinical need, technical feasibility, and procurement criteria align to accelerate adoption.

How distinct regulatory regimes, procurement models, and clinical infrastructures across the Americas, EMEA, and Asia-Pacific are shaping adoption trajectories and vendor strategies

Regional dynamics materially influence technology adoption, regulatory interaction, and clinical validation pathways. In the Americas, health systems often emphasize outcome-driven procurement, strong institutional research networks, and a willingness to invest in early clinical validation, which accelerates pilot programs and iterative deployments. The availability of specialized neurosurgical centers and concentrated academic hubs also supports rapid evidence generation and clinician training initiatives that catalyze broader uptake.

Across Europe, the Middle East and Africa, the regulatory landscape and reimbursement frameworks shape deployment timing and required evidence packages. Cost containment pressures in some jurisdictions increase demand for scalable, interoperable solutions that demonstrate clear improvements in throughput or clinical outcomes. Meanwhile, capacity constraints and uneven access to subspecialty care in parts of the region create opportunities for remote support models and cloud-enabled analytics to extend expertise. In the Asia-Pacific region, a combination of rapid hospital expansion, government-led technology adoption programs, and a competitive local manufacturing base drives heterogeneity in procurement strategies. The region often balances aggressive adoption of robotics and imaging with a strong emphasis on cost-effectiveness and supply chain resilience.

Competitive behaviors and strategic imperatives for companies pursuing leadership through integrated solutions, clinical evidence generation, and innovative commercial models

Key company behaviors cluster around several strategic priorities that determine market positioning and long-term competitiveness. First, firms that integrate end-to-end solutions-combining imaging or navigation hardware with validated AI software and robust service offerings-create higher switching costs for customers and can justify premium contracting models. Second, partnerships between clinical systems integrators, imaging vendors, and specialist AI developers are becoming the norm to accelerate regulatory submissions and clinical studies, sharing both risk and evidence-generation responsibilities.

Third, successful companies invest in longitudinal clinical validation and real-world evidence programs that demonstrate safety, reproducibility, and workflow impact; these programs are instrumental in gaining clinician trust and payer recognition. Fourth, firms that design for modularity and interoperability reduce integration friction with existing hospital infrastructures, which shortens procurement cycles. Finally, commercial models diversify beyond capital sales to include managed services, outcome-based contracts, and subscription licensing for analytics, aligning vendor incentives with clinical performance and operational uptime. Observing these behaviors helps inform competitive responses and potential partnership targets.

Actionable strategic moves for market leaders to accelerate adoption, de-risk deployments, and align commercial models with clinical outcomes and procurement realities

Industry leaders must pursue a balanced set of strategic moves that align clinical validation, procurement complexity, and technological differentiation. Prioritize building demonstrable clinical evidence through multi-center studies and clinician-led pilots that measure not only technical accuracy but also workflow impact, user acceptance, and downstream clinical outcomes. Simultaneously, structure commercial offers to reduce customer risk by bundling integration, training, and maintenance services with hardware and software, thereby lowering operational friction for early adopters.

To mitigate supply-chain and policy risks, diversify component sourcing and consider selective localization for critical assemblies. Invest in interoperable architectures and open APIs to ease integration with hospital information systems and existing imaging fleets. From a technology standpoint, focus development on explainable models and human-in-the-loop interfaces that enhance surgeon control and regulatory acceptability. Finally, cultivate partnerships with leading clinical centers and payers to build shared value propositions that link technology deployment to demonstrable improvements in clinical and operational metrics.

A robust multi-method research approach combining clinician interviews, technology assessment, regulatory review, and supply chain mapping to ensure evidence-based conclusions

The report's methodology combines primary research with rigorous secondary analysis and clinical validation to ensure findings are evidence-based and actionable. Primary inputs include structured interviews with practicing neurosurgeons, operating room nurses, biomedical engineers, hospital procurement officers, and technology executives, supplemented by direct observation of intraoperative workflows where available. These primary insights are triangulated with device technical specifications, regulatory filings, and peer-reviewed clinical literature to verify claims and contextualize results.

Technology assessments evaluate algorithmic approaches, training datasets, compute footprints, and integration complexity. Supply chain mapping traces component origins, assembly locations, and logistics risks to surface vulnerabilities. Regulatory reviews encompass device classification, approval timelines, and post-market surveillance obligations. Data synthesis employed a layered approach that weights clinical impact, technical readiness, and commercial viability to produce balanced recommendations while avoiding quantitative market sizing beyond the scope of qualitative and evidentiary analysis.

Concluding synthesis on how clinical validation, interoperable design, and resilient commercial strategies form the foundation for lasting adoption of AI in neurosurgery

Artificial intelligence is transitioning from a promising adjunct to a foundational layer that supports safer, more precise neurosurgical procedures. The technology's value is realized when hardware fidelity, validated algorithms, and service models coalesce to reduce intraoperative uncertainty, improve procedural efficiency, and extend specialist expertise. However, achieving this future depends on disciplined clinical validation, interoperable system design, resilient supply chains, and thoughtful commercial models that align incentives between vendors and clinical institutions.

Stakeholders who invest in modular architectures, longitudinal evidence programs, and strong clinician engagement programs will be best positioned to capture the clinical and economic benefits of AI-enabled neurosurgery. Policymakers and hospital leaders should encourage frameworks that reward demonstrable improvements in patient outcomes and operational performance, while vendors should emphasize explainability, reliability, and supportability as core product attributes. Taken together, these elements form the foundation for sustained, responsible adoption of AI in neurology operating rooms.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Deployment of deep learning models for automated real-time detection of neural tissue boundaries during resective brain surgery
• 5.2. Adoption of AI-driven predictive analytics to forecast patient-specific surgical risks and outcomes in neurosurgical procedures
• 5.3. Implementation of augmented reality systems powered by machine learning for surgeon guidance in complex cranial surgeries
• 5.4. Integration of AI-based workflow optimization platforms to streamline neurosurgical OR scheduling and reduce procedure time
• 5.5. Development of multimodal AI algorithms combining electrophysiological signals and imaging data for intraoperative decision support
• 5.6. Utilization of federated learning frameworks for multicenter AI training on neurosurgical imaging while preserving patient privacy
• 5.7. Emergence of robotics integrated with AI vision systems for enhanced precision in minimally invasive neurological interventions

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Intelligence in Neurology Operating Room Market, by Component

• 8.1. Hardware
  • 8.1.1. Imaging Systems
  • 8.1.2. Navigation Systems
  • 8.1.3. Robotic Systems
• 8.2. Services
  • 8.2.1. Integration Services
  • 8.2.2. Maintenance Services
  • 8.2.3. Training Services
• 8.3. Software
  • 8.3.1. AI Platforms
  • 8.3.2. Analytics Software
  • 8.3.3. Predictive Algorithms

9. Artificial Intelligence in Neurology Operating Room Market, by Application

• 9.1. Intraoperative Imaging
  • 9.1.1. CT
  • 9.1.2. MRI
  • 9.1.3. Ultrasound
• 9.2. Predictive Analytics
  • 9.2.1. Outcome Prediction
  • 9.2.2. Workflow Optimization
• 9.3. Robotic Assistance
  • 9.3.1. Neuroendoscopic Robots
  • 9.3.2. Robot-Assisted Microscopy
• 9.4. Surgical Navigation
  • 9.4.1. Electromagnetic Navigation
  • 9.4.2. Optical Navigation

10. Artificial Intelligence in Neurology Operating Room Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Hospitals And Clinics
• 10.3. Research Institutes

11. Artificial Intelligence in Neurology Operating Room Market, by Technology

• 11.1. Computer Vision
  • 11.1.1. 3D Reconstruction
  • 11.1.2. Image Segmentation
• 11.2. Deep Learning
  • 11.2.1. Convolutional Neural Networks
  • 11.2.2. Recurrent Neural Networks
• 11.3. Machine Learning
  • 11.3.1. Supervised Learning
  • 11.3.2. Unsupervised Learning
• 11.4. Natural Language Processing
  • 11.4.1. Clinical Report Analysis
  • 11.4.2. Literature Mining

12. Artificial Intelligence in Neurology Operating Room Market, by Deployment

• 12.1. Cloud
• 12.2. On Premise

13. Artificial Intelligence in Neurology Operating Room Market, by Surgery Type

• 13.1. Deep Brain Stimulation
• 13.2. Epilepsy Surgery
• 13.3. Tumor Resection

14. Artificial Intelligence in Neurology Operating Room Market, by Anatomy Target

• 14.1. Brain
• 14.2. Spinal Cord

15. Artificial Intelligence in Neurology Operating Room Market, by Region

• 15.1. Americas
  • 15.1.1. North America
  • 15.1.2. Latin America
• 15.2. Europe, Middle East & Africa
  • 15.2.1. Europe
  • 15.2.2. Middle East
  • 15.2.3. Africa
• 15.3. Asia-Pacific

16. Artificial Intelligence in Neurology Operating Room Market, by Group

• 16.1. ASEAN
• 16.2. GCC
• 16.3. European Union
• 16.4. BRICS
• 16.5. G7
• 16.6. NATO

17. Artificial Intelligence in Neurology Operating Room Market, by Country

• 17.1. United States
• 17.2. Canada
• 17.3. Mexico
• 17.4. Brazil
• 17.5. United Kingdom
• 17.6. Germany
• 17.7. France
• 17.8. Russia
• 17.9. Italy
• 17.10. Spain
• 17.11. China
• 17.12. India
• 17.13. Japan
• 17.14. Australia
• 17.15. South Korea

18. Competitive Landscape

• 18.1. Market Share Analysis, 2024
• 18.2. FPNV Positioning Matrix, 2024
• 18.3. Competitive Analysis
  • 18.3.1. Siemens Healthineers AG
  • 18.3.2. GE HealthCare Technologies Inc.
  • 18.3.3. Koninklijke Philips N.V.
  • 18.3.4. Medtronic plc
  • 18.3.5. Stryker Corporation
  • 18.3.6. Zimmer Biomet Holdings, Inc.
  • 18.3.7. Globus Medical, Inc.
  • 18.3.8. Brainlab AG
  • 18.3.9. Renishaw plc
  • 18.3.10. Carl Zeiss Meditec AG

LIST OF FIGURES

• FIGURE 1. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEPLOYMENT, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGERY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2024 VS 2032 (%)
• FIGURE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANATOMY TARGET, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AMERICAS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. NORTH AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. LATIN AMERICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. EUROPE ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. MIDDLE EAST ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. AFRICA ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. ASEAN ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. GCC ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. EUROPEAN UNION ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. BRICS ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. G7 ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. NATO ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 33. ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 34. ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NAVIGATION SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTEGRATION SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MAINTENANCE SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TRAINING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AI PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ANALYTICS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ALGORITHMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY INTRAOPERATIVE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MRI, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY PREDICTIVE ANALYTICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OUTCOME PREDICTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY WORKFLOW OPTIMIZATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOTIC ASSISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY NEUROENDOSCOPIC ROBOTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ROBOT-ASSISTED MICROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY SURGICAL NAVIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY ELECTROMAGNETIC NAVIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY OPTICAL NAVIGATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY COMPUTER VISION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY 3D RECONSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY IMAGE SEGMENTATION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 219. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 220. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY DEEP LEARNING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 225. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 226. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 227. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 228. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY CONVOLUTIONAL NEURAL NETWORKS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 229. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 230. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 231. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 232. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 233. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 234. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY RECURRENT NEURAL NETWORKS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 235. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2018-2024 (USD MILLION)
• TABLE 236. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, 2025-2032 (USD MILLION)
• TABLE 237. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 238. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 239. GLOBAL ARTIFICIAL INTELLIGENCE IN NEUROLOGY OPERATING ROOM MARKET SIZE, BY MACHINE LEARNING,